Atlas Trials

Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

Clinical trial NCT07472387 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07472387
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma (GBM)
Start date
2026-04-01
Primary completion
2030-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.